Nadine Bizouarne
Transgene (France)(FR)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Virus-based gene therapy research, Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, Poxvirus research and outbreaks
Most-Cited Works
- → Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial(2011)265 cited
- → A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer(2008)202 cited
- → Gene-based vaccines and immunotherapeutics(2004)183 cited
- → Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer(2003)172 cited
- → Recombinant Vaccinia Virus Encoding Human MUC1 and IL2 as Immunotherapy in Patients With Breast Cancer(2000)130 cited
- → MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines(2000)95 cited
- → MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure(2008)80 cited
- → Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2(2003)44 cited
- → Targeted Macrophage Cytotoxicity Using a Nonreplicative Live Vector Expressing a Tumor-Specific Single-Chain Variable Region Fragment(2000)23 cited
- → Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell-conditioned media(1996)23 cited